• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    LSL Pharma Closes Second Tranche Of Private Placement And Units For Debt

    GLOBENEWSWIRE

    LSL Pharma Group Announces Voting Results Of Annual and Meeting Of Shareholders

    GLOBENEWSWIRE

    LSL Secures $1.5 Million as First Closing of Its Non-Brokered Private Placement

    GLOBENEWSWIRE

    LSL Pharma Completes Acquisition Of Virage Santé

    GLOBENEWSWIRE

    LSL Pharma Group Announces Engagement of Red Cloud Securities

    GLOBENEWSWIRE

    SCHOTT, KORU: Collaboration For Large Volume Subcutaneous Infusions

    GLOBENEWSWIRE

    LSL Pharma Group Reports Record Revenues and Margins for the First Quarter 2024

    GLOBENEWSWIRE

    LSL Pharma Lists Convertible Debentures On TSXV

    GLOBENEWSWIRE

    LSL Pharma Group Enters Into Binding Agreement to Acquire Quebec Competitor

    GLOBENEWSWIRE

    LSL Pharma Q4 & FY 2023 Results, Highlights

    GLOBENEWSWIRE

    LSL Pharma Secures $3.8M Final Private Placement Tranche

    GLOBENEWSWIRE

    LSL Pharma Group Announces the Addition of New Members to Its Board of Directors

    GLOBENEWSWIRE

    LSL Pharma Upsizes Private Placement To $7.5M

    GLOBENEWSWIRE

    LSL Pharma Joins 2024 Bloom Burton Healthcare Conference

    GLOBENEWSWIRE

    LSL Pharma $6.44 M as the First Closing of Concurrent Non-Brokered Private

    GLOBENEWSWIRE

    LSL Pharma Group Announces a Combination of Private Placements

    GLOBENEWSWIRE

    LSL Pharma Group Announces an Extension of its Convertible Debentures Offering

    GLOBENEWSWIRE

    LSL Announces Closing of Second Tranche of Convertible Debentures Offering

    GLOBENEWSWIRE

    LSL Pharma Group Appoints Luc Mainville as Chief Financial Officer

    GLOBENEWSWIRE

    LSL Pharma Group Announces its Results for the Third Quarter of Fiscal 2023

    GLOBENEWSWIRE

    LSL Pharma Announces Closing of First Tranche of Convertible Debentures Offering

    GLOBENEWSWIRE

    Groupe LSL Pharma Announces New Orders with an Annual Revenue Potential

    GLOBENEWSWIRE

    LSL Pharma Group Announces Exclusive Distribution Agreement With Fera Pharma

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.